Profil
Palle Christophersen is the founder of Cephagenix ApS, founded in 2020, and Saniona AB, founded in 2011, where the title held is Executive Vice President-Research.
The current job is Chief Scientific Officer at Saniona A. Former job includes Vice President & Director-Vitro Pharmacology at NTG Nordic Transport Group A from 1991 to 2012.
Education includes a doctorate from the University of Copenhagen.
Aktiva positioner av Palle Christophersen
| Företag | Position | Start |
|---|---|---|
| SANA AB | Grundare | 2011-01-01 |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Teknisk/Vetenskaplig/F&U Direktör | - |
Tidigare kända positioner av Palle Christophersen
| Företag | Position | Slut |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Företagsledare/Principal | 2012-01-01 |
Cephagenix ApS
Cephagenix ApS BiotechnologyHealth Technology Engages in identifying and developing new, effective migraine therapies | Grundare | - |
Palle Christophersens utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
NTG Nordic Transport Group A/S
NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saniona AB
Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Commercial Services |
Cephagenix ApS
Cephagenix ApS BiotechnologyHealth Technology Engages in identifying and developing new, effective migraine therapies | Health Technology |
















